Novacyt (LON:NCYT) Stock Price Down 1% – Here’s Why

by · The Cerbat Gem

Novacyt S.A. (LON:NCYT – Get Free Report)’s share price was down 1% during mid-day trading on Wednesday . The company traded as low as GBX 47.58 ($0.60) and last traded at GBX 49.20 ($0.62). Approximately 221,097 shares traded hands during trading, a decline of 59% from the average daily volume of 543,508 shares. The stock had previously closed at GBX 49.70 ($0.63).

Novacyt Trading Down 1.0 %

The company’s 50 day simple moving average is GBX 59.16 and its 200 day simple moving average is GBX 60.18. The company has a debt-to-equity ratio of 18.67, a current ratio of 4.04 and a quick ratio of 4.46. The firm has a market cap of £34.75 million, a price-to-earnings ratio of -94.62 and a beta of -1.86.

Novacyt Company Profile

(Get Free Report)

Novacyt SA, together with its subsidiaries, provides in vitro and molecular diagnostic tests for a range of infectious diseases in the United Kingdom, rest of Europe, the United States, the Asia Pacific, the Middle East, and Africa. It operates through Primer Design, Lab21 Products, and IT-IS International segments.

Recommended Stories